Vir Biotechnology target raised to $22 from $17 by Leerink Partners
VIR•Leerink Partners raised its price target for Vir Biotechnology to $22 from $17.
Related News
Public Storage: Jefferies raises target price to $392 from $319
PSA•
Vir Biotechnology: Needham raises target price to $24 from $20
VIR•
Canada's HIVE Digital Q2 revenue falls 2.7% year over year
HIVE•
Palomar Holdings, Inc.: KBW raises target price to $172 from $161
PLMR•
Qualys target price cut to $215 from $241 by JPMorgan
QLYS•